75 related articles for article (PubMed ID: 16889383)
21. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains.
Kim YJ; Neelamegam R; Heo MA; Edwardraja S; Paik HJ; Lee SG
J Microbiol Biotechnol; 2008 Jun; 18(6):1186-90. PubMed ID: 18600066
[TBL] [Abstract][Full Text] [Related]
22. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
Demirgöz D; Garg A; Kokkoli E
Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells.
Sharma S; Tammela J; Wang X; Arnouk H; Driscoll D; Mhawech-Fauceglia P; Lele S; Kazim AL; Odunsi K
Clin Cancer Res; 2007 Oct; 13(19):5889-96. PubMed ID: 17908984
[TBL] [Abstract][Full Text] [Related]
24. Improving GPX activity of selenium-containing human single-chain Fv antibody by site-directed mutation based on the structural analysis.
Xu J; Song J; Yan F; Chu H; Luo J; Zhao Y; Cheng X; Luo G; Zheng Q; Wei J
J Mol Recognit; 2009; 22(4):293-300. PubMed ID: 19277948
[TBL] [Abstract][Full Text] [Related]
25. [Screening and characterization of human phage Fab antibody gene to prostate specific membrane antigen].
Huang H; Huang J; Lin TX; Xu KW; Guo ZH; Jiang C; Han JL
Zhonghua Nan Ke Xue; 2007 Jul; 13(7):601-4. PubMed ID: 17725301
[TBL] [Abstract][Full Text] [Related]
26. Cloning, expression, and identification of anti-carbofuran single chain Fv gene.
Wang H; Yang J; Liu X; Liang Y; Lei H; Shen Y; Xu X; Sun Y; Xu Z; He Y
Biotechnol Prog; 2009; 25(4):1018-24. PubMed ID: 19653307
[TBL] [Abstract][Full Text] [Related]
27. Regulation of prostate-specific antigen expression by the junctional adhesion molecule A.
Wang Q; Zheng JY; Kreth J; Yan X; Kamata M; Campbell RA; Xie Y; Chiu R; Berenson JR; Shi W; Chen IS; Pang S
Urology; 2009 May; 73(5):1119-25. PubMed ID: 18602143
[TBL] [Abstract][Full Text] [Related]
28. Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid.
Vellinga J; de Vrij J; Myhre S; Uil T; Martineau P; Lindholm L; Hoeben RC
Gene Ther; 2007 Apr; 14(8):664-70. PubMed ID: 17268536
[TBL] [Abstract][Full Text] [Related]
29. [Construction and expression of anti-clenbuterol single chain Fv recombinant vector].
Wang H; Liang Y; Yang J; Liu X; Zhang H; Lei H; Shen Y; Sun Y
Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1470-4. PubMed ID: 18998553
[TBL] [Abstract][Full Text] [Related]
30. Immobilization of homing peptide on magnetite nanoparticles and its specificity in vitro.
Gan ZF; Jiang JS; Yang Y; Du B; Qian M; Zhang P
J Biomed Mater Res A; 2008 Jan; 84(1):10-8. PubMed ID: 17600321
[TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R
Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666
[TBL] [Abstract][Full Text] [Related]
32. Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer.
Gross M; Top I; Laux I; Katz J; Curran J; Tindell C; Agus D
Clin Cancer Res; 2007 Apr; 13(7):1979-86. PubMed ID: 17404077
[TBL] [Abstract][Full Text] [Related]
33. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer cell proliferation in vitro is modulated by antibodies against glucose-regulated protein 78 isolated from patient serum.
Gonzalez-Gronow M; Cuchacovich M; Llanos C; Urzua C; Gawdi G; Pizzo SV
Cancer Res; 2006 Dec; 66(23):11424-31. PubMed ID: 17145889
[TBL] [Abstract][Full Text] [Related]
35. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
Sardana G; Jung K; Stephan C; Diamandis EP
J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
[TBL] [Abstract][Full Text] [Related]
36. Prostate-specific membrane antigen and its truncated form PSM'.
Mlcochová P; Barinka C; Tykvart J; Sácha P; Konvalinka J
Prostate; 2009 Apr; 69(5):471-9. PubMed ID: 19107881
[TBL] [Abstract][Full Text] [Related]
37. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.
Stoll P; Bassler N; Hagemeyer CE; Eisenhardt SU; Chen YC; Schmidt R; Schwarz M; Ahrens I; Katagiri Y; Pannen B; Bode C; Peter K
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1206-12. PubMed ID: 17322097
[TBL] [Abstract][Full Text] [Related]
38. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F
BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428
[TBL] [Abstract][Full Text] [Related]
39. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
40. Advances in specific immunotherapy for prostate cancer.
Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
